Silodosin: Difference between revisions
m Protected "Silodosin": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)) |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
| Line 25: | Line 25: | ||
}} | }} | ||
{{SI}} | {{SI}} | ||
'''Silodosin''' is an α<sub>1</sub>-[[adrenoceptor]] [[antagonist]] with high uroselectivity. It appears to be more effective than [[tamsulosin]] in relieving urinary symptoms associated with [[benign prostatic hyperplasia]] (BPH). | '''Silodosin''' is an α<sub>1</sub>-[[adrenoceptor]] [[antagonist]] with high uroselectivity. It appears to be more effective than [[tamsulosin]] in relieving urinary symptoms associated with [[benign prostatic hyperplasia]] (BPH). | ||
| Line 33: | Line 33: | ||
*[http://www.medscape.com/viewarticle/548919 Medspace.com atricle] | *[http://www.medscape.com/viewarticle/548919 Medspace.com atricle] | ||
[[Category:Alpha blockers]] | [[Category:Alpha blockers]] | ||
Revision as of 16:03, 20 August 2012
|
WikiDoc Resources for Silodosin |
|
Articles |
|---|
|
Most recent articles on Silodosin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Silodosin at Clinical Trials.gov Clinical Trials on Silodosin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Silodosin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Silodosin Discussion groups on Silodosin Directions to Hospitals Treating Silodosin Risk calculators and risk factors for Silodosin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Silodosin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Silodosin is an α1-adrenoceptor antagonist with high uroselectivity. It appears to be more effective than tamsulosin in relieving urinary symptoms associated with benign prostatic hyperplasia (BPH).